Biomedical

Researchers from the California NanoSystems Institute (CNSI) at the University of California, Los Angeles, have developed a patented technology that can inhibit and prevent the growth of pancreatic cancer in the liver. The technology’s goal is to reprogram the liver’s immune defense to attack pancreatic cancer. Key to this technology are liver-targeting nanoparticles that deliver two key components: an mRNA vaccine targeting an immune-activating marker commonly found in pancreatic cancer, and a small molecule that boosts the immune response.

Using an approach called DNA origami, scientists at Caltech have developed a technique that could lead to cheaper, reusable biomarker sensors for quickly detecting proteins in bodily fluids, eliminating the need to send samples out to lab centers for testing. DNA origami enables long strands of DNA to fold, through self-assembly, into molecular structures at the nanoscale. In this study, DNA origami was used to create a lilypad-like structure – a flat, circular surface about 100 nanometers in diameter, tethered by a DNA linker to a gold electrode.

Researchers from the University of Pennsylvania, Rutgers University, and East China University of Science and Technology in Shanghai have shown that a combination of messenger RNA (mRNA) and a new lipid nanoparticle could help heal damaged lungs. The researchers matched up mRNA with just one unique lipid nanoparticle – ionizable amphiphilic Janus dendrimers – which are organ-specific. When it reaches the lung, the mRNA instructs the immune system to create transforming growth factor beta, a signaling molecule that is used to repair tissue.

Researchers from Baylor College of Medicine and Pennsylvania State University have discovered that Zika virus builds a series of tiny tubes, called tunneling nanotubes, that facilitate the transfer of viral particles to neighboring uninfected cells. The tiny conduits also provide a means to transport RNA, proteins and mitochondria, a cell’s main source of energy, from infected to neighboring cells.

Researchers from Cedars-Sinai Cancer; Caltech; California State University, Northridge; and Technion-Israel Institute in Haifa, Israel, have designed nanobioparticles that can cross the protective blood–brain barrier and deliver therapy directly into cancerous tumor cells. The findings could help clinicians target brain tumors previously unreachable by chemotherapy.

Researchers at the University of Pennsylvania have demonstrated that ferumoxytol, an U.S. Food and Drug Administration-approved iron oxide nanoparticle formulation, greatly reduces infection in patients diagnosed with apical periodontitis. The researchers showed that topical applications of ferumoxytol in combination with hydrogen peroxide potently disrupt biofilms – dense, sticky communities of bacteria that attach to surfaces and cause infections.

Using the nanostructures and microstructures found on Morpho butterfly wings, scientists at the University of California San Diego have developed a simple and inexpensive way to analyze cancerous tissues. Fibrosis, the accumulation of fibrous tissue, is a key feature of many diseases, including cancer, and evaluating the extent of fibrosis in a biopsy sample can help determine whether a patient’s cancer is in an early or advanced stage.

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system that can deliver messenger RNA (mRNA) to the brain via intravenous injection – a challenge that has long been limited by the protective nature of the blood-brain barrier. The system takes advantage of natural transport mechanisms within the blood-brain barrier that move nanoparticles across the blood-brain barrier.

Researchers from Vanderbilt University have developed advanced dialysis membranes using an atomically thin material called graphene. These innovative membranes leverage a protein-enabled sealing mechanism that works as follows: When proteins escape through larger pores, they react with molecules on the other side of the graphene membrane. This reaction triggers a sealing process, selectively closing larger pores while preserving smaller ones. This self-sealing capability ensures precise size-selective filtration and improves the membrane's overall effectiveness.

A major challenge in self-powered wearable sensors for health care monitoring is distinguishing different signals when they occur at the same time. Now, researchers from Penn State and Hebei University of Technology in China have addressed this issue by developing a new type of flexible sensor that can accurately measure both temperature and physical strain simultaneously but separately, potentially enabling better wound healing monitoring.